We are supported in this mission by experienced and accomplished scientists and clinicians, a novel portfolio of programs, leading healthcare investors, and pharma company partners, who share in our commitment to bettering the lives of patients and realizing a world where we make brain disorders history. Hands-on experience analyzing high-content imaging data, including cell segmentation, feature extraction, and qualification, as well as high-dimensional biological datasets, such as bulk or single-cell RNA sequencing or proteomics.